Find an expert

Professor Andrew Barbour is an academic general surgeon who specialises in upper gastrointestinal, pancreatic, melanoma and sarcoma surgery.

On completion of his training, Dr Barbour worked at the Bristol Royal Infirmary as an Upper Gastrointestinal and Hepatobiliary Surgery Fellow and then as a Surgical Oncology Fellow at the Memorial Sloan-Kettering Cancer Centre, New York.

Professor Andrew Barbour specializes in the treatment of oesophageal, gastric, and pancreatic diseases, as well as melanoma and soft tissue tumours. He has expertise in minimally invasive treatments these conditions, including robotic surgery, minimally invasive oesophagectomy, laparoscopic anti-reflux surgery (fundoplication), laparoscopic gastrectomy, and laparoscopic pancreatectomy.

Professor Barbour’s research interests are in the treatment of cancer. His academic interests have encompassed the areas of 1) clinical research, including randomised controlled clinical trials, 2) laboratory based research, including molecular biology pertinent to upper gastrointestinal disease, pancreatic cancer and melanoma, 3) translational research integrating the laboratory and clinical domains, and 4) health-related quality of life and patient reported outcomes research.

As a clinical researcher, Prof Barbour has been active in the conduct of clinical trials at Phase I, II and III levels. He was the Principal Investigator for investigator initiated, multicentre phase II trials in oesophageal (DOCTOR trial) and pancreatic cancer (GAP Trial), funded by the NH&MRC and sponsored by the Australasian Gastrointestinal Trials Group (AGITG). Both of these national trials include biological substudies with tumour tissue and blood banking and subsequent molecular analyses aimed at answering specific questions, including the identification of biomarkers of response to therapy. These studies are aimed at developing personalized, precision therapy for cancer. The DOCTOR trial was the first trial to use PET scans to “tailor” or “personalize” therapy for patients with oesophageal cancer. The GAP trial has shown that pre-operative chemotherapy is a safe strategy for patients with pancreatic cancer. Building on the GAP trial, the AGITG has undertaken the MRFF funded MASTERPLAN clinical trial for pancreatic cancer exploring th e role of stereotactic radiation in pancreatic cancer. Professor Barbour is the Chair of the AGITG Upper GI working party and a member of the AGITG Board.

Prof Barbour is a translational researcher at the School of Medicine, The University of Queensland. He is the head of Surgical Oncology Lab at the School of Medicine. His research has focused on using genomic, epigenomic, mRNA expression and next generation sequencing data to classify oesophageal adenocarcinoma (OAC), pancreatic cancer and melanoma and to identify biomarkers of outcome. His lab team was the first to identify genomic catastrophes as potential drivers for oesophageal adenocarcinoma. In addition, his lab is seeking to identify genetic markers in melanoma that will identify patients at high risk for recurrence following surgery and to identify patients who will benefit from the current exciting advances in treatment for advanced melanoma. His work in melanoma is supported by a Queensland Advancing Clinical Research Fellowship. He was also a member of the Australian Pancreatic Cancer Genome Initiative (APGI) that has published several key studies that have improved our understanding of pancreatic cancer. His lab is currently undertaking studies using next generation sequencing of tumour and circulating tumour DNA. Professor Barbour is the Chief Investigator for the Cancer Evolution Biobank based at the Translational Research Institute. This biobank contains tumour tissue and blood from patients with melanoma, oesophageal or gastric cancer linked to clinical outcomes and supports several research projects.

I am an academic paediatric neurologist, clinical researcher, and specialist in acquired brain injury in children and adolescence. I studied at the University of Edinburgh and British Columbia before taking up my first academic position at the University of Calgary in 2002. Here I developed and directed the Traumatic Brain Injury and Concussion Research Program at the Alberta Children's Hospital and where I cemented my interest in the biology and treatment of children with brain injuries. I have extensive clinical research experience, devising and overseeing clinical trials in children both nationally and internationally. I moved to the Child Health Research Centre at the University of Queensland, Australia in October 2017 and joined the Queensland Paediatric Rehabilitation Service and Queensland Cerebral Palsy Rehabililation Centre to facilitate research into improving the health outcomes of children with acquired brain injury in Queensland and Australia.

My research focuses on the neurobiological signatures and treatment of subtle neurological dysfunction in mild traumatic brain injury and concussion, especially the behavioural and cognitive impairments that are found in post-concussion syndrome. I use multimodal neurological assessments to do this. My research explores combining neuroimaging and neurophysiological investigations, including perfusion studies using MRI (ASL-fMRI) and transcranial magnetic stimulation to help us understand the changes in the brain in children who are slow to recovery following a concussion. This is to help us develop and assess more effective and tailored treatments for children with concussion and traumatic brain injury. I explore novel therapies for children with persistent post-concussive symptoms in clinical trials including the use of neuraceuticals, pharmacotherapies, and non-invasive brain stimulation treatment.

I am the director of the newly-established KidStim Lab at the Child Health Research Centre. This is the first non-invasive neuromodulation facility aimed at improving the health outcomes of children with brain injury in Australia and is led by a mulitdisciplinary team of clinicians and scientists from Brisbane bring a unique clinical and scientific knowledge-base to help achieve our goals. Rehabilitation therapy in combination with repetitive transcranial direct current stimulation (rTMS) and other direct current stimulation modalities (e.g. tDCS) will be explored. It also offers the potential for treatment of the mood and behavioural disorders (e.g. depression and anxiety) commonly seen after brain injury but also so disruptive to the life of the normally developing teenager.

Dr Ben Barry is an allied health professional working clinically in aged care with Wesley Mission Queensland.

Dr Barry has a research background in adaptations of the nervous system to exercise and ageing. His research interests have progressed to health professional education, spanning digital health, interprofessional education and workforce development. Dr Barry's clinical work as a physiotherapist and exercise physiologist with a focus on healthy ageing links nicely with his PhD thesis on "Resistance training and movement control in older adults".

Dr Barry has extensive experience teaching allied health (exercise physiology), medical science and medical students. This has included coordinating degree programs and courses, leading teaching teams and discipline-wide curriculum reviews, expanding and enhancing clinical placement programs and student clinics, and innovations in online teaching of health professionals.

Dr Barry completed postdoctoral training in the Neurophysiology of Movement Laboratory at the Department of Integrative Physiology, the University of Colorado - Boulder USA, and subsequently worked for a decade at the School of Medical Sciences, The University of New South Wales, as well as holding an honorary appointment at Neuroscience Research Australia, before returning to The University of Queensland in 2017. He has a track record of external research funding and postgraduate research supervision as well as several teaching awards.

Markus graduated from the Vienna University of Technology in Technical Physics in 1995 and was awarded his Doctorate in 1999 after which he worked as postdoctoral research associate and then Assistant Professor at the Department of Radiodiagnostics, Medical University Vienna (AT). From 2004 he worked as Senior Researcher at the Donders Institute for Brain, Cognition and Behaviour (Radboud University Nijmegen, NL) and at the Erwin L. Hahn Institute for Magnetic Resonance Imaging (University Essen-Duisburg, DE). In 2014 he relocated to the University of Queensland to head the Ultra-high Field Human MR Research program at the Centre for Advanced Imaging and was awarded an ARC Future Fellowship. In 2019 he joined the School of Information Technology and Electrical Engineering as Full Professor Biomedical Engineering working on MR Physics and Medical Imaging. He served as Imaging, Sensing and Biomedical Engineering Discipline lead until 2020 when he took up service roles as Deputy Head of School – Research, Director for the National Imaging Facility – Queensland Node, as well as a member of the ARC College of Experts.

A/Prof Federica Barzi is a Principal Research Fellow in Biostatistics at the UQ Poche Centre for Indigenous Health and within the Faculty of Health and Behavioral Sciences at The University of Queensland. She was awarded a PhD in Epidemiology and Biostatistics from Sydney University in 2004 and has a BSc degree in Statistics from the University of Padova, Italy.

A/Prof Barzi is an applied Biostatistician with extensive experience on study design and data analysis of randomized clinical trials, very large observational studies and data linkage. She has worked across a variety of specialties including cardiology, nephrology, nutrition, oncology and emergency care. She has been involved in Indigenous Health since 2005 and from April 2014, with her appointment at the Menzies School of Health Research in Darwin, A/Prof Barzi’s contribution to research focuses solely on Aboriginal and Torres Strait Islander Health. She has co-authored over a hundred and thirty peer reviewed journal articles with colleagues from various institutions and has secured, as a CI, over 24M in research funding since 2006.

Dr Lizzie Beadle is a clinical psychologist, neuropsychologist, and researcher. Her research is focused on neuropsychological rehabilitation, changes to self-awareness and identity after brain injury, and use of technology in rehabilitation. She has practiced as a psychologist from acute through to community services. She is experienced in translation of research in to clinical practice. She is passionate about supporting a lifelong love of learning in students and clinicians. She is also passionate about supporting greater medical and lifestyle choice and control for individuals with disabilities.

Scott Beatson is an Associate Professor and NHMRC Career Development Fellow at The University of Queensland (UQ). He specializes in bacterial pathogenomics: using whole-genome sequencing to investigate transmission, pathogenesis and antibiotic resistance in bacteria. Recent work from his group includes genomic analyses of pandrug resistant enterobacteriaceae and the multidrug resistant Escherichia coli ST131 pandemic clone. He was awarded a PhD from UQ for his work in bacterial pathogenesis in 2002 and developed his career in bacterial genomics in the United Kingdom with the support of fellowships from the Royal Commission for the Exhibition of 1851 (University of Oxford) and the UK Medical Research Council (University of Birmingham). Since returning to Australia he has held fellowships from both the NHMRC and ARC and has led a successful research group in the School of Chemistry and Molecular Biosciences at UQ since 2008. He is also a member of the Australian Infectious Diseases Research Centre and the Australian Centre for Ecogenomics. In 2016 he received the Frank Fenner Award from the Australian Society for Microbiology in recognition of his contribution to microbiology research in Australia.

Stefanie was awarded a PhD in Cognitive Psychology / Experimental Psychology in 2007, from the University of Bielefeld, Germany, and was subsequently awarded two awards for it (amongst them the National German Dissertation Award). She then took up a 1-year post-doc position with Prof Roger Remington at UQ. Subsequently, her work was supported by various fellowships from UQ and the ARC, allowing Stefanie to focus mainly on research from 2009 - 2018. Afterwards she was employed on a Teaching and Research position at UQ, where she is currently employed as an Associate Professor.

Personal website: www.sibecker.com

As a teaching and research academic within the School of the Environment at the University of Queensland, I research the biology and genetics of mosquitoes in our region of the Indo-Pacific that delivers fundamental knowledge into the role mosquitoes play in mosquito-borne disease. This work moves across basic and applied research and has advanced our understanding of mosquitoes, their evolution, species’ distributions, permitting better focused mosquito control to be imagined. More recent research involves exploring new environmentally friendly biological control tools such as using the Wolbachia bacterium and genetic modification to combat mosquito-borne disease.

For more detail on my research please see below and at this link http://www.nigelbeebe.com

Associate Professor Jakob Begun is the IBD Group leader in the Immunity, Infection, and Inflammation Program at Mater Research University of Queensalnd, and has a basic and translational laboratory at the Translational Research Institute in Brisbane. He is an Associate Professor in the University of Queensland Faculty of Medicine. After completing his Bachelor of Science at Cornell University Jakob attended Cambridge University where he completed an MPhil in Biochemistry. He then moved on to Harvard Medical School where he completed his MD and PhD in genetics studying the host pathogen interaction using C. elegans as a model system. He completed his clinical training in internal medicine at Brigham and Women’s hospital and went on to complete general gastroenterology training at Massachusetts General Hospital (MGH) as well as advanced training in the treatment of Inflammatory Bowel Disease (IBD).

Dr Begun first joined Mater Research - University of Queensland in 2014, and at the same time received a clinical staff appointment in Gastroenterology at the Mater Hospital Brisbane. His clinical activities are focussed on the treatment and mangement of patients with IBD. He is the director of the IBD unit at the Mater Hospital Brisbane and at the Mater Young Adult Health Centre Brisbane .In January 2015 he was awarded the University of Queensland Reginald Ferguson Fellowship in Gastroenterology to support his research activity. He leads a basic and translational laboratory at the Translational Research Institute investigating the interaction between the innate immune system and the gut microbiome, as well as genetic contributions to disease. He also performs clinical research examining predictors of response to therapy, minimising barriers of care for adolescents and young adults with IBD, improving outcomes in pregnancy and IBD, and the use of intestinal ultrasound in IBD. He is the chair of the Gastroenterology Society of Australia-IBD Faculty and of the president of the Gastroenterology Network of Intestinal Ultrasound (GENIUS).

A/Prof Stephen Bell is a senior social scientist, advisor and international development research consultant with 23 years’ experience tackling global health challenges in settings across South-East Asia, Africa, Western Pacific and Europe. He works respectfully with not-for-profits, public institutions, businesses and community organisations, using innovative, inclusive, people-centred approaches to identify sustainable solutions to critical health challenges and accelerate health equity.

As Principal Research Fellow and ‘Theme Lead - Social Science and Global Health’ at the Burnet Institute, Steve’s role includes:

• Research on young people's sexual, reproductive and maternal health, including adolescent-responsive health services and systems, contraceptive innovation, safe abortion, enabling socio-structural environments, and the intersections of health and climate change;
• Providing methodological expertise, technical support and mentoring in social science, co-design and community-based, community-led research practice across the Institute’s global health programs and business development across working groups and programs;
• Supporting a growing regional network of youth research, advocacy and thought leadership hubs across Asia and the Pacific;
• Managing and delivering consultancy, advisory and research work for institutional partners.

Steve’s work brings together lived experience, socio-ecological systems thinking and social theory to understand what works (or not) in global health and social development. He has researched and published widely on HIV, sexual and reproductive health, maternal health, neglected tropical diseases, TB and Indigenous health. He is particularly interested in understanding the socio-structural determinants of health and social inequities, and injustices associated with marginalisation due to gender, sexuality, age and geography. He has published two edited collections on interpretive and community-led approaches in research, design, monitoring and evaluation: ‘Peer research in health and social development: international perspectives on participatory research’ (2021), and ‘Monitoring and evaluation in health and social development: interpretive and ethnographic perspectives’ (2016). With international colleagues, he is working on a third edited collection called, ‘Lived Experience: Critical Perspectives in a Changing World’. Steve is currently taking on new PhD students who are interested in undertaking research in any of these areas, so please do reach out to him for a chat!

Steve is Commissioner on The Lancet Global Health Commission on People-Centered Care for Universal Health Coverage, Technical Consultant (Strategy and Insights) with PSI, and Member of the International Editorial Board at Culture, Health & Sexuality. Steve has served as a Senior Advisor to the Boston Consulting Group, and has worked in senior research and consultancy roles with international governments, NGOs, UNAIDS, UNFPA and WHO.

Electrophysiology of synaptic transmission, ion currents and central pattern generation in CNS neurones.

Current research focuses on the electrophysiology of central nervous system neurones using various in vitro slice and in vivo preparations, patch clamp techniques, imaging, molecular biology and computer modelling.

Projects include :

• Neurobiology of motor control
• Motor neuron disease
• Synaptic transmission in the cochlear nucleus
• Potassium currents in the brainstem and cerebellum
• Rhythmic control of breathing movements

Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.

Dr Kath Benfer is a Post-Doctoral Research Fellow with the Queensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland. Her Post-Doctoral work focuses on community-based early detection and intervention for infants at high risk of cerebral palsy in low-resource countries (India and Bangladesh). She was awarded the prestigious Endeavour Queen Elizabeth II Diamond Jubilee Scholarship through the Australian Commonwealth Government to conduct the study. Kath’s PhD explored oropharyngeal dysphagia, gross motor function, growth and nutrition in preschool children with cerebral palsy, in both Australia and Bangladesh. Her work arising from her doctoral studies has been published in 10 peer-reviewed publications and presented widely at international conferences. Dr Benfer has over 12 years of experience as a speech pathologist within paediatric disability, with community-based child and family support services. Kath also has an interest in cross-cultural issues in child health, having worked in Bangladesh for over 2 years both as an AusAid volunteer teaching on the country’s first Bachelor of Speech Therapy degree, as well as conducting research in this context. She has completed her Master of Public Health at La Trobe University in Melbourne within the research and international health streams.

Sally Bennett is a Professor in Occupational Therapy and implementation scientist in the School of Health and Rehabilitation Sciences. Her research interests are in knowledge translation, implementation, evidence-based practice, care of people with dementia, and use of standardised patients for teaching. Sally is a Fellow of the Occupational Therapy Australia Research Academy (FOTARA) that recognises sustained exemplary and impactful contribution to occupational therapy research. She has been Associate Editor of the Canadian Journal of Occupational Therapy and the Australian Occupational Therapy Journal and on the committee of the OTA Research Foundation, and earlier roles in the World Federation of Occupational Therapists. She is an editor and author of a widely used inter-disciplinary evidence-based practice book (Evidence-Based Practice across the Health Professions) that is now in its 4th edition.

Sally's interest in knowledge translation and evidence based practice extends to research, teaching and service roles both nationally and internationally. She led a large NHMRC Grant together with colleagues from Australia and the USA investigating the implementation of an evidence-based occupational therapy program for peoople with dementia, Australia-wide. Sally co-led an an industry funded research project to evaluate the impact of a knowledge translation capacity building inititiative for a large number of therapists in Queensland Health designed to support their application of knowledge translation methods within their clinical specialty areas, which has had direct clinical impact.

After receiving a PhD on immune regulation from La Sorbonne Universitas in France, Anne-Sophie joined Prof. Ian Frazer’s lab in Australia where she led a highly successful and independent research program on the mechanisms of immune tolerance in human papillomavirus (HPV)-associated lesions in mice. She then joined the field of autoimmune diseases with Prof. Ranjeny Thomas. In Type 1 Diabetes, her pre-clinical data showed the feasibility of an antigen-specific liposome targeted immunotherapy in pre-diabetic mice and led to the first-in-human clinical trial using liposome nanoparticles. In Spondyloarthropathy, her interest is focused on deciphering the link between the gut microbiome, the immune system and the development of arthritic inflammation.